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The efficacy of bacterial vaccines to prevent respiratory diseases in swine: A
protocol for a systematic review
Abstract
The treatment and prevention of infectious diseases in pigs is an important aspect of swine production
worldwide. The prudent use of antimicrobials and other therapeutic drugs is a primary responsibility of swine
producers and veterinarians and decisions surrounding the use of drug therapy include considerations such as
cost, efficacy, and food safety. The World Health Organization has published numerous reports urging all
stakeholders concerned with both food-producing animals and humans to establish recommended steps to
enhance the prudent use of antimicrobials (WHO, 2015). Similarly, the Organization for Animal Health has
also published recommendations and position statements regarding prudent use and risk management related
to antimicrobial use in animals (OIE, 2017).
Antibiotic therapy is used to treat and prevent respiratory diseases in pigs and there are numerous pathogenic
organisms involved in all of the predominant swine respiratory diseases (Karriker, et al, 2012). In addition to
antibiotics, vaccines targeted towards respiratory pathogens have been used extensively in swine production
and are often used in combination with other approaches to reduce the incidence of disease. The usefulness of
a vaccine or vaccine program varies from herd to herd and the complex interactions between host, agent and
environment in swine production makes the design of a vaccine program challenging for veterinarians. There
are many studies that have assessed the efficacy of antibiotics and vaccines for the treatment and prevention
Mycoplasma hyopneumonia, for example, however, they often report conflicting results adding to the
complexity of the decision-making process (Thacker and Minion, 2012).
Understanding the efficacy of these vaccines products is essential to optimizing their use in order to decrease
reliance on antibiotics for both treatment and prevention of swine respiratory disease. Systematic reviews of
randomized controlled trials in these areas will yield the highest level of evidence for efficacy of treatment
under field conditions (Sargeant and O’Connor, 2014). Although vaccines exist for both viral and bacterial
causes of respiratory diseases of swine, and antibiotics often are used in the treatment of both, this review will
focus on bacterial causes for logistical reasons.
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using	 the	 approach	 proposed	 by	 GRADE	 (GRADE,	 2015,	 Puhan	 et	 al.,	 2014),	 while	 also	
considering	the	nature	of	the	network	meta-analysis	 (Jansen	et	al.,	2011).	 	 If	 feasible,	we	will	
use	the	framework	from	the	CINeMA	platform	for	conveying	the	impact	of	risk	of	bias	on	the	
network	performance.				
	
Discussion:		
	
This	systematic	review	will	provide	a	synthesis	of	the	current	evidence	regarding	the	efficacy	of	
vaccines	to	prevent	bacterial	diseases	causing	respiratory	diseases	in	swine.		Results	will	be	
helpful	for	veterinarians	and	swine	producers	when	making	evidence-informed	decisions	
regarding	management	options	to	reduce	respiratory	illness	and	death	caused	based	bacteria,	
and	potentially	reduce	the	need	to	use	antibiotics	to	treat	respiratory	diseases.		The	results	also	
will	be	helpful	for	identifying	specific	gaps	in	knowledge	related	to	the	efficacy	of	these	vaccine	
for	targeting	additional	research.	
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